chrisvoncsefalvay/vaers-outcomes huggingface dataset:
this is a 59-year-old female with past medical history of epilepsy, intraparenchymal hemorrhage in December 2020, residual right-sided weakness, hypertension, hyperlipidemia, and deficiency anemia, chronic GERD, depression, history of status epilepticus, morbid obesity.   She came to the hospital with a chief complaint of an episode of seizure.  Witnessed by her husband.  Patient was reporting that she was told that she was having generalized tonic clonic movements.  She did not require intubation.  She was given Ativan by the EMS.  Seizure resolved in the emergency room.  Patient is awake and oriented currently.  She denies any chest pain, shortness of breath, palpitations, abdomin Tested positive on 01/01/2022 Additional information for Item 18:  this is a 59-year-old female with past medical history of epilepsy, intraparenchymal hemorrhage in December 2020, residual right-sided weakness, hypertension, hyperlipidemia, and deficiency anemia, chronic GERD, depression, history of status epilepticus, morbid obesity.      She came to the hospital with a chief complaint of an episode of seizure.  Witnessed by her husband.  Patient was reporting that she was told that she was having generalized tonic clonic movements.  She did not require intubation.  She was given Ativan by the EMS.  Seizure resolved in the emergency room.  Patient is awake and oriented currently.  She denies any chest pain, shortness of breath, palpitations, abdominal pain, nausea, vomiting, burning or painful urination, diarrhea.  She did report some subjective fevers, chills and cough and multiple family members having upper respiratory tract infections him.  So I decided to test her for COVID-19.
This is an instance of breakthrough COVID-19 after which death occurred. The individual was vaccinated with the Pfizer product on 07/30/2021 and 08/20/2021. The individual presented to emergency department on 01/15/2022 with primary complaints of severe abdominal pain. They were admitted to hospital same day and tested positive for COVID-19  on 01/16/2022. Due to the complexity of the situation (the individual had several underlying medical conditions), they were transferred to a different hospital on 01/16/2022. Their health continued to deteriorate and required ventilation. They died on 01/20/2022. The cause of the abdominal pain was not determined.
Temporary blurred vision; increased her nearsightedness from -1.25 to -1.75; corneal edema/ Corneal topographies showed swelling in the cornea; This is a spontaneous report from a contactable other healthcare professional. A 43-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot number EL0140), intramuscular (left arm, dose number 1) on 01Jan2021 16:45 at single dose for COVID-19 immunization. Medical history included known allergies to penicillin and sulfa antibiotics, hormonal migraines, and gluten intolerance from an unknown date and unknown if ongoing. Concomitant medication included cetirizine hydrochloride (ZYRTEC), and spironolactone from unspecified dates for unspecified indications taken within two weeks. No other vaccine was taken within four weeks. Patient has not COVID prior vaccination. Patient has not been tested for COVID post vaccination. The patient experienced temporary blurred vision in the right eye on 02Jan2021. Patient stated that she is an optometrist so she performed a variety of tests and determined she had corneal edema.  Corneal topographies showed swelling in the cornea, increased her nearsightedness from -1.25 to -1.75. By the time she left work 7 hours later, her vision and corneal topographies returned back to normal. Treatment was not given for the events. Event outcome was recovered on 02Jan2021. The reporter assessed the event was non-serious.
Headache began 13 days later.  Had to be checked out of school due to severity of headache. Daily, chronic headaches have persisted from August 23rd. Other adverse neurological issues progressed from there.  Pain, numbing sensation on left side of body, memory loss, disassociative feeling, behavioral issues, verbal outbursts, a decline in school performance. Trouble speaking correctly,  writing words out of sequence within a sentence.
Swollen infraclavicular lymph node on left side after second vaccine in left arm.; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 31 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 22Apr2021 14:30 (Batch/Lot number: unknown) at the age of 31 years as dose 2, single for covid-19 immunisation. Relevant medical history included: "Asthma" (unspecified if ongoing); "Known allergies: Shellfish" (unspecified if ongoing). The patient's concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose 1, Manufacturer: Pfizer, Administration time: 04:45 PM, Anatomical location: Right arm, Lot: unknown), administration date: 01Apr2021, when the patient was 31 years old, for COVID-19 immunisation, reaction(s): "Swollen infraclavicular lymph node on right side after first vaccine in right arm.". The following information was reported: LYMPHADENOPATHY (non-serious) with onset Apr2021, outcome "unknown", described as "Swollen infraclavicular lymph node on left side after second vaccine in left arm.". Therapeutic measures were not taken as a result of lymphadenopathy.  Additional information: Patient did not have covid prior vaccination. Patient did not have Covid tested post vaccination. Patient did not take any other vaccine in four weeks.  No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
I had some mild redness on my arms and on my hip areas. The most concerning was a blue spot on one of my hands...a small blue line. I felt a little feverish and tired as well. I got the vaccine on Sunday. Monday night I felt the side effects and Tuesday I was better and the blue spot on my hand and the red spots were gone as well.
fatigue; sore arm; Flu like symptoms; developed a lump on the left side of her clavicle; painful to touch; This is a spontaneous report from a Contactable consumer (parent). A 15-years-old female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Lot Number: EW0178), via an unspecified route on 19Jul2021 at 11:00 (at the age of 15-years) as dose 2, single in the left arm for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Lot Number: EW0172), via an unspecified route on 28Jun2021 at 14:30 (at the age of 15-years) as dose 1, single in the left arm for covid-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient experienced and developed a lump on the left side of her clavicle. She said the lump was squishy, and painful to touch and had fatigue, flu like symptoms, sore arm on 20Jul2021. It was explained that with the first dose her daughter was fine, she didn't hurt or anything. Yesterday her daughter felt fatigue and all that, which is normal but then reported the lump on her clavicle. It is on the left side, the same side of the shot on the clavicle. Reporter says her daughter was not quite as tired today. Yesterday she felt like she had a mild flu which they told her would be normal. She also had the sore arm and are using ice packs to treat that. The lump on the clavicle is a bit bigger than quarter and if they push on it, it hurts. She read on the internet that this might be normal and put a heat pack on it but she wanted to call us first and was then going to call the doctor. Patient did not visit to Emergency Room or Physician Office. The outcome of the events developed a lump on the left side of her clavicle was not recovered, painful to touch, sore arm, flu like symptoms was unknown, fatigue was recovering.  Follow-up attempts are completed. No further information is expected.
day aft vax child devel fever 104 F w/ crying and screaming.  child was very stiff (increased muscle tone) and was unconsolable for several hrs.  pt recovered.
fever 103 for 3 days; sores appeared on mouth on 3rd day;
Information has been received from a female patient of unknown age, who is also a physician, via a company representative. The patient's medical history, concurrent conditions, concomitant medications and drug reactions/allergies were not provided. On an unknown date (reported as "approximately 2 years prior to the second dose"), the patient was vaccinated with the first dose of PNEUMOVAX23 (strength, dose, route of administration, lot# and expiration date were not reported), for prophylaxis. Subsequently, on an unknown date, the patient was hospitalized for an unspecified adverse event and during the hospitalization she was vaccinated with the second dose of PNEUMOVAX23 (strength, dose, route of administration, lot# and expiration date were not reported), for prophylaxis. The patient indicated that she was not aware that she was vaccinated with the second dose at the time. On an unknown date, the patient experienced a severe reaction at the injection site; her whole arm was swollen and red. It was reported that an unspecified treatment was given for the adverse event. At the time of reporting, the patient recovered from the reaction at the injection site. The outcome of the adverse event, which caused the hospitalization was unknown. The causality assessment between PNEUMOVAX23 and the events was not reported. Additional information has been requested.
Increased seizure activity. Mom states patient developed seizure approximately 1 hour after influenza vaccine injection was administered.
Information has been received from a consumer referring to her son, a male patient of unknown age. The information of concurrent conditions, medical history and concomitant medications was not provided. On an unknown date, the patient was vaccinated with the first dose of GARDASIL (lot number, dose, frequency and route were not provided). On an unknown date, at the sight of the insertion, there was a bump which was not red just at the normal skin problem, but the bump never went away. But then, the patient's mother chose to end the treatment. Additional information is not expected since there is no contact information provided.
Pt experienced breakthrough chickenpox with a rash all over the torso, neck and extremities. Pt was exposed to chickenpox at school on an unknown date. The dx was made by a physician. Follow-up information from a physician indicated that the pt was vaccinated at a different physician's office. No further information is available.
severe period cramps; arm hurts; This is a spontaneous report from a contactable consumer (patient). A 33-year-old female patient received bnt162b2 (Pfizer-Biontech Covid-19 vaccine), dose 3 via an unspecified route of administration on 28Oct2021 (Batch/Lot number was not reported) at the age of 33-years-old as dose 3 (booster), single for covid-19 immunisation. Medical history included endometriosis and patient is allergic to shrimp (patient is still getting tested) from an unknown date and unknown if ongoing. The patient is not pregnant at the time of vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19 and since the vaccination, the patient has not been tested for COVID-19. Concomitant medication(s) included influenza vaccine (FLU) taken for an unspecified indication from Sep2021 to Sep2021; levonorgestrel (KYLEENA) taken for an unspecified indication, start and stop date were not reported, paracetamol (TYLENOL) and vitamins taken for an unspecified indication, start and stop date were not reported. The patient previously received dose 1 of bnt162b2 on 11Jan2021 and dose 2 on 01Feb2021 both at the age of 32-years-old for Covid-19 immunization. On 28Oct2021, the patient experienced severe period cramps an hour after getting the shot and arm hurts. The patient did not receive treatment for the events. The outcome of the event was not recovered.  The lot number for the vaccine, BNT162B2, was not provided and will be requested during follow up.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202101479859 same patient, suspect drug and event; different dose
PFIZER-BIONTECH COVID-19 VACCINE EUA.  ADMINISTRATION ERROR:  Resident documented as receiving 3 doses of vaccine.  First dose of Pfizer COVID-19 vaccine on 1/20/21.  Second dose on 2/10/21.  Resident was vaccinated on 3/3/21 with new consent form stating no prior dose of vaccine.  Patient has no adverse reactions reported to date.
On April 27th, I experienced shortness of breath, close to fainting episodes, rapid heart beat, light headness, exhaustion. On May 9th, 2 days after my second dose I experienced rapid heart rate at 279 beats per minute according to Fire Fighter, Paramedic reported it at 200bpm upon their arrival. Paramedic stopped my heart to reset it because it would not slow down. I was reportedly not getting oxygen in my blood and little flow to my body which cause me to be lightheaded and unable to stand. I experienced severe sore throat. ER Dr, diagnosed me with PSVT
Arthus reaction left shoulder - Swelling, pain, redness, fatigue started day after ADACEL administration - Tx MEDROL, Ibuprofen
1st day: Vaccine a.m. 1st night: insomia, arm pain, achey muscles 2nd day:  joint pain and achey muscles.   Heachache 2nd night: diminishing arm pain and aches. 3rd day: still some arm pain.   Fatigue, diminishing aches.
pt described not feeling "right" within minutes of vaccination. I had her sit down and describe her symptoms. She descibed feeling hot and flushed. she also desribed a pain in her chest that "didnt seem right" She was visibly flushed and sweating. After sitting she also described sharp pains in her back and would occasionally jerk due to the pain. At this point I activated EMS. During the phone call with 911 she described shortness of breathe. I told her to stay calm and focus on breathing, and if it gets worse at all let me know. After that point she stated that she was feeling better. EMS arrived within 5 minutes or so and they took over. The paramedics then transported her to the ER.
GBS. Started 12/1/11 with weakness and balance problems. Recurrent episodes still occur presently.
pT. GOT THE FLU VACCINE AND 48 HOURS THE LEFT ARM STARTED TO SWELL INCLUDING THE SOFT TISSUE AROUND THE NECK. AREA WAS SWOLLEN, SLIGHTLY WARM AND ONE LYMPHADENOPATHY.
This spontaneous report as received from a licensed practical nurse refers to a patient of unknown age and gender. There were no concomitant medications, concurrent conditions and medical history reported. On 10-AUG-2015 the patient was vaccinated with a dose of improperly stored PROQUAD (Merck) (lot # K018144, expiration date 10-APR-2016, dose, dose# and route not reported). There was no adverse events reported. This is one of several reports received from the same reporter. Additional information has been requested.
Client's eyes are swelling and has swollen lymph nodes on left side of her neck and around her ear. Started on 5/5/15 after vaccination. Has been to her doctor and to the ER.
I got so sick for at least a week after each; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP), Program ID: (005570). The reporter is the patient.  A patient (no qualifiers provided) received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose: 1), for Covid-19 Immunization, reaction(s): "I got so sick for at least a week after each"; Bnt162b2 (Dose: 2), for Covid-19 Immunization, reaction(s): "I got so sick for at least a week after each". The following information was reported: ILLNESS (non-serious), outcome "unknown", described as "I got so sick for at least a week after each".  Additional information: I have had 3 covid-19 vaccinations. I got so sick for at least a week after each. Must I have another shot?  The information on the batch/lot number for BNT162b2, BNT162b2 omi ba.4-5 has been requested and will be submitted if and when received.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202300219751 Same patient, different dose, same event;US-PFIZER INC-PV202300104327 Same patient, different dose, same event;
Feeling light headed 5 minutes after vaccine given, diminished but five minutes after that, lightheadedness came back again also reported blocked, pressure feeling in ears. States few years back reacted to flu vaccine with weight gain, fluid retention.
High fever, muscle aches and pains, shaking started past midnight. Was resting and maintained fluid intake until fever and shaking stopped a few hours later, around 3:30 or 4:00 a.m.
GARDASIL given and approx 30 sec later felt faint-recovered by lying down
pt began to feel bad felt hot to touch - real hot per mom all noc; mom had no thermometer; pt vomited & was unable to keep anything on stomach all noc; also had h/a; stomache, heart racing; irritable warm to touch & sore; 3 diarrhea;
Patient is currently breastfeeding; Patient is currently breastfeeding; Nodules to left cheek and glabella; This is a spontaneous report from a contactable healthcare professional. A 41-year-old breast feeding female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number: Unknown), via an unspecified route of administration on 30Apr2021 (at the age of 41-year-old), as 2nd dose, single dose, for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient's past medications included restylane Lyft and restylane L. The patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number: Unknown), via an unspecified route of administration on 09Apr2021, as single dose for COVID-19 immunization. On 13May2021, 13 days after the second shot, the patient developed nodules to left cheek and glabella. Nodules were palpable but not visible. The treatment medications included Clindamycin and Medrol dose pack. The clinical outcome of the event nodules to left cheek and glabella was not resolved. The clinical outcome of all other events was unknown.  Information about batch/lot number has been requested.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021647606 Same reporter, different events
lt upper arm form shoulder to below elbow w/raised red rash, warm to touch, fine rash over torso 24MAY97;
Itching and swelling at injection site 9 days after receiving the shot.  Rash on right check as well. Was very sore for 2 days after getting injection as well.
Pain in right foot.  Pain between ankle all the way up to knee.  Waking up in night with tingling and sharp pain.
near immediate lump in throat that increased to a sensation that I might not be able to swallow within approximately 20 minutes.  I maintained the ability to swallow.  Shortly after the throat swelling, my eyes began to itch.  This was followed by general face itching.  I also experienced a metallic taste in my mouth within 15 minutes of the dose.  I took a Benadryl at around 8 PM after my throat and the itching had not resolved.  The benadryl resolved the itching and ease the swollen throat.  My throat remained tight feeling the next day, but was normal feeling by 4/11/21.
Twitching; feel very weak; tired; sick to my stomach; mental health is bad right now; feel very off and not myself at all; Twitching and spasms in my legs; This spontaneous case was reported by a consumer and describes the occurrence of MUSCLE TWITCHING (Twitching), ASTHENIA (feel very weak), FATIGUE (tired), ABDOMINAL DISCOMFORT (sick to my stomach) and MENTAL DISORDER (mental health is bad right now) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced MUSCLE TWITCHING (Twitching), ASTHENIA (feel very weak), FATIGUE (tired), ABDOMINAL DISCOMFORT (sick to my stomach), MENTAL DISORDER (mental health is bad right now), MALAISE (feel very off and not myself at all) and MUSCLE SPASMS (Twitching and spasms in my legs). At the time of the report, MUSCLE TWITCHING (Twitching), ASTHENIA (feel very weak), FATIGUE (tired), ABDOMINAL DISCOMFORT (sick to my stomach), MENTAL DISORDER (mental health is bad right now), MALAISE (feel very off and not myself at all) and MUSCLE SPASMS (Twitching and spasms in my legs) outcome was unknown.            No concomitant medications were reported.  No treatment medications were reported.
Initial report received from a healthcare professional and follow-up information on 20 February 2014. A 8-year-old female patient, who had no known allergies and illness at the time of vaccination was unknown, had received an intramuscular dose of FLUZONE QIV (lot number: U4767AA, dose number was not reported) in the left deltoid on 18 October 2013. It was reported that the patient had received flu vaccines previously on an unspecified dates. On 18 October 2013 after vaccination, the patient had local pain with left arm weakness. The patient had daily pain in the arm for 4 months. The patient was complaining pain (once localized to the injection site), which involves the entire arm. The patient had difficulty carrying items in her left arm secondary to apparent muscle fatigue in the affected extremity. Physical examination was unrevealing: no redness or swelling involving the extremity, no motor or sensory deficit, ROM intact, no muscle wasting. Laboratory investigation and corrective treatment were not reported. On an unspecified date, the patient had recovered from events. Documents held by sender: none. Addendum: 06 March 2014. Upon second medical examination of case at time of internal review the following has been modified in this case. The event coding of the verbatim difficulty "carrying items in her left arm secondary to apparent muscle fatigue in the affected extremity" was corrected from left arm weakness to Muscle fatigue. The labelling in the assessment screen was corrected from unlabelled to labelled.
TIA event 2 weeks after the second dose of the COVID vaccine. Sharp shooting pain in right temple followed by bilateral central vision loss for 2 minutes then left eye kaleidoscope vision for 2 hours.  Treated in the ED as a stroke.
One day post vax pt developed an injection site reaction characterized by redness and warmth. Pt was treated with warm compresses.